Risk of QTc prolongation among cancer patients treated with tyrosine kinase inhibitors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Risk of QTc prolongation among cancer patients treated with tyrosine kinase inhibitors

Published:2020-07-16 Issue:11 Volume:147 Page:3160-3167
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Abu Rmilah Anan A.¹²^ORCID,Lin Grace²,Begna Kebede H.³,Friedman Paul A.²,Herrmann Joerg²

Affiliation:

1. William J. von Liebig Center for Transplantation and Clinical Regeneration Mayo Clinic Rochester Minnesota USA

2. Department of Cardiovascular Medicine Mayo Clinic Rochester Minnesota USA

3. Department of Internal Medicine, Division of Hematology Mayo Clinic Rochester Minnesota USA

Funder

The National Cancer Institute

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.33119

Reference31 articles.

1. Evaluation and Management of Patients With Heart Disease and Cancer: Cardio-Oncology

2. Adverse effects of anticancer agents that target the VEGF pathway

3. Protein kinases — the major drug targets of the twenty-first century?

4. Cardiotoxicity of Tyrosine-Kinase-Targeting Drugs

5. FDA-approved small-molecule kinase inhibitors

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. QT-Interval Prolongation, Torsades de Pointes, and Heart Failure With EGFR Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer: Systematic Review;Clinical Lung Cancer;2024-06

2. QTc Interval: A frequently unrecognized electrocardiographic interval;The American Journal of the Medical Sciences;2024-05

3. Biomarkers navigate drug development: Pharmacology, effectiveness and safety;Medicine in Drug Discovery;2024-02

4. Prevention and Management of Cardiotoxicity Caused by Chemotherapeutic Agents;Complications of Cancer Therapy: Best Practices in Prevention and Management;2024

5. Arrhythmias and Conduction Disorders in HSCT;Cardiovascular Considerations in Hematopoietic Stem Cell Transplantation;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3